Beyond CCR7: dendritic cell migration in type 2 inflammation

Conventional dendritic cells (cDCs) are crucial antigen-presenting cells that initiate and regulate T cell responses, thereby shaping immunity against pathogens, innocuous antigens, tumors, and self-antigens. The migration of cDCs from peripheral tissues to draining lymph nodes (dLNs) is essential f...

Full description

Saved in:
Bibliographic Details
Main Authors: Audrey Meloun, Beatriz León
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1558228/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850229265395613696
author Audrey Meloun
Audrey Meloun
Beatriz León
author_facet Audrey Meloun
Audrey Meloun
Beatriz León
author_sort Audrey Meloun
collection DOAJ
description Conventional dendritic cells (cDCs) are crucial antigen-presenting cells that initiate and regulate T cell responses, thereby shaping immunity against pathogens, innocuous antigens, tumors, and self-antigens. The migration of cDCs from peripheral tissues to draining lymph nodes (dLNs) is essential for their function in immune surveillance. This migration allows cDCs to convey the conditions of peripheral tissues to antigen-specific T cells in the dLNs, facilitating effective immune responses. Migration is primarily mediated by chemokine receptor CCR7, which is upregulated in response to homeostatic and inflammatory cues, guiding cDCs to dLNs. However, during type 2 immune responses, such as those triggered by parasites or allergens, a paradox arises—cDCs exhibit robust migration to dLNs despite low CCR7 expression. This review discusses how type 2 inflammation relies on additional signaling pathways, including those induced by membrane-derived bioactive lipid mediators like eicosanoids, sphingolipids, and oxysterols, which cooperate with CCR7 to enhance cDC migration and T helper 2 (Th2) differentiation. We explore the potential regulatory mechanisms of cDC migration in type 2 immunity, offering insights into the differential control of cDC trafficking in diverse immune contexts and its impact on immune responses.
format Article
id doaj-art-5172d5c9b9c84811a6ffb3e82ebd7cfe
institution OA Journals
issn 1664-3224
language English
publishDate 2025-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-5172d5c9b9c84811a6ffb3e82ebd7cfe2025-08-20T02:04:18ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-02-011610.3389/fimmu.2025.15582281558228Beyond CCR7: dendritic cell migration in type 2 inflammationAudrey Meloun0Audrey Meloun1Beatriz León2Innate Cells and Th2 Immunity Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL, United StatesInnate Cells and Th2 Immunity Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United StatesConventional dendritic cells (cDCs) are crucial antigen-presenting cells that initiate and regulate T cell responses, thereby shaping immunity against pathogens, innocuous antigens, tumors, and self-antigens. The migration of cDCs from peripheral tissues to draining lymph nodes (dLNs) is essential for their function in immune surveillance. This migration allows cDCs to convey the conditions of peripheral tissues to antigen-specific T cells in the dLNs, facilitating effective immune responses. Migration is primarily mediated by chemokine receptor CCR7, which is upregulated in response to homeostatic and inflammatory cues, guiding cDCs to dLNs. However, during type 2 immune responses, such as those triggered by parasites or allergens, a paradox arises—cDCs exhibit robust migration to dLNs despite low CCR7 expression. This review discusses how type 2 inflammation relies on additional signaling pathways, including those induced by membrane-derived bioactive lipid mediators like eicosanoids, sphingolipids, and oxysterols, which cooperate with CCR7 to enhance cDC migration and T helper 2 (Th2) differentiation. We explore the potential regulatory mechanisms of cDC migration in type 2 immunity, offering insights into the differential control of cDC trafficking in diverse immune contexts and its impact on immune responses.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1558228/fulldendritic cell migrationtype 2 immune responsesCCR7cysteinyl leukotrienes (cysLTs)sphingosine-1-phosphate (S1P)7α,25-Dihydroxycholesterol (7α,25-OHC)
spellingShingle Audrey Meloun
Audrey Meloun
Beatriz León
Beyond CCR7: dendritic cell migration in type 2 inflammation
Frontiers in Immunology
dendritic cell migration
type 2 immune responses
CCR7
cysteinyl leukotrienes (cysLTs)
sphingosine-1-phosphate (S1P)
7α,25-Dihydroxycholesterol (7α,25-OHC)
title Beyond CCR7: dendritic cell migration in type 2 inflammation
title_full Beyond CCR7: dendritic cell migration in type 2 inflammation
title_fullStr Beyond CCR7: dendritic cell migration in type 2 inflammation
title_full_unstemmed Beyond CCR7: dendritic cell migration in type 2 inflammation
title_short Beyond CCR7: dendritic cell migration in type 2 inflammation
title_sort beyond ccr7 dendritic cell migration in type 2 inflammation
topic dendritic cell migration
type 2 immune responses
CCR7
cysteinyl leukotrienes (cysLTs)
sphingosine-1-phosphate (S1P)
7α,25-Dihydroxycholesterol (7α,25-OHC)
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1558228/full
work_keys_str_mv AT audreymeloun beyondccr7dendriticcellmigrationintype2inflammation
AT audreymeloun beyondccr7dendriticcellmigrationintype2inflammation
AT beatrizleon beyondccr7dendriticcellmigrationintype2inflammation